作者
Blake P Gillette, Lori J DeSimone, Robert T Trousdale, Mark W Pagnano, Rafael J Sierra
发表日期
2013/1/1
期刊
Clinical Orthopaedics and Related Research®
卷号
471
期号
1
页码范围
150-154
出版商
LWW
简介
Background
The use of antifibrinolytic medications in hip and knee arthroplasty reduces intraoperative blood loss and decreases transfusion rates postoperatively. Tranexamic acid (TXA) specifically has not been associated with increased thromboembolic (TE) complications, but concerns remain about the risk of symptomatic TE events, particularly when less aggressive chemical prophylaxis methods such as aspirin alone are chosen.
学术搜索中的文章
BP Gillette, LJ DeSimone, RT Trousdale, MW Pagnano… - Clinical Orthopaedics and Related Research®, 2013